NeoGenomics Inc

Company Profile

NeoGenomics Inc had its IPO on 2004-03-16 under the ticker symbol NEO.

The company operates in the TRADE & SERVICES sector and SERVICES-TESTING LABORATORIES industry. NeoGenomics Inc has a staff strength of 0 employees.

Stock update

Shares of NeoGenomics Inc opened at $7.59 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $7.31 - $7.85, and closed at $7.34.

This is a -4.05% slip from the previous day's closing price.

A total volume of 1,542,709 shares were traded at the close of the day’s session.

In the last one week, shares of NeoGenomics Inc have slipped by -8.25%.

NeoGenomics Inc's Key Ratios

NeoGenomics Inc has a market cap of $0.923 billion, indicating a price to book ratio of 0.903 and a price to sales ratio of 1.887.

In the last 12-months NeoGenomics Inc’s revenue was $0.489 billion with a gross profit of $0.192 billion and an EBITDA of $-0.106 billion. The EBITDA ratio measures NeoGenomics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, NeoGenomics Inc’s operating margin was -34.1% while its return on assets stood at -5.65% with a return of equity of -13.4%.

In Q2, NeoGenomics Inc’s quarterly earnings growth was a positive 130.6% while revenue growth was a positive 2.8%.

NeoGenomics Inc’s PE and PEG Ratio

Forward PE

222.22

Trailing PE

-

PEG

3.02

Its diluted EPS in the last 12-months stands at $-0.294 per share while it has a forward price to earnings multiple of 222.22 and a PEG multiple of 3.02. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NeoGenomics Inc’s profitability.

NeoGenomics Inc stock is trading at a EV to sales ratio of 2.224 and a EV to EBITDA ratio of 343.81. Its price to sales ratio in the trailing 12-months stood at 1.887.

NeoGenomics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

NeoGenomics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

NeoGenomics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

NeoGenomics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, NeoGenomics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, NeoGenomics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$7.34

52-Week High

$44.26

52-Week Low

$6

Analyst Target Price

$16.78

NeoGenomics Inc stock is currently trading at $7.34 per share. It touched a 52-week high of $44.26 and a 52-week low of $44.26. Analysts tracking the stock have a 12-month average target price of $16.78.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.